Key statistics
On Monday, MaxCyte Inc (MYE0:FRA) closed at 0.67, 20.72% above the 52 week low of 0.555 set on Feb 19, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 0.66 |
|---|---|
| High | 0.67 |
| Low | 0.66 |
| Bid | -- |
| Offer | -- |
| Previous close | 0.66 |
| Average volume | 123.20 |
|---|---|
| Shares outstanding | 106.67m |
| Free float | 99.74m |
| P/E (TTM) | -- |
| Market cap | 86.54m USD |
| EPS (TTM) | -0.4298 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 14:25 GMT.
More ▼
Announcements
- MaxCyte unveils ExPERT DTx™, a 96-well electroporation platform to accelerate discovery
- MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026
- MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results
- MaxCyte Announces Planned CFO Transition in 2026
- MaxCyte Reports Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance
- MaxCyte Reports Preliminary Third Quarter 2025 Financial Results and Reiterates Full Year 2025 Revenue Guidance
- MaxCyte to Report Third Quarter 2025 Financial Results on November 5, 2025
- MaxCyte Announces Strategic Platform License Agreement with Moonlight Bio to Advance T Cell Therapies for Solid Tumors
- MaxCyte Announces Operational Restructuring to Reduce Costs and Accelerate Path to Profitability
- MaxCyte Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Guidance
More ▼
